Anti jun

Manufactured by Proteintech

Sourced in United States

The Anti-JUN product is a laboratory reagent that detects the JUN protein, which is a transcription factor involved in various cellular processes. This antibody can be used in techniques such as Western blotting, immunoprecipitation, and immunohistochemistry to identify and quantify the JUN protein in biological samples.

Automatically generated - may contain errors

Lab products found in correlation

Protease inhibitor tablet, by Thermo Fisher Scientific (1 mentions) Anti hif 1α, by Proteintech (1 mentions) Anti α tubulin, by Proteintech (1 mentions) Ripa buffer, by Beyotime (1 mentions) Ab109617, by Abcam (1 mentions) Anti mcl1 16225 1 ap, by Proteintech (1 mentions) Anti myc, by Proteintech (1 mentions) Anti myc tag, by Proteintech (1 mentions) Anti stat3 12640, by Cell Signaling Technology (1 mentions) Anti ubiquitin 3936, by Cell Signaling Technology (1 mentions) Anti β actin, by Proteintech (1 mentions) Anti flag tag, by Proteintech (1 mentions)

2 protocols using anti jun

Whole Cell Lysate Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Whole cell lysates were obtained by re-suspending cell pellets in RIPA buffer (Beyotime, P0013E) with a freshly added protease inhibitor tablet (Thermo Scientific, 88265). Western blot analyses were performed with anti-β-actin (Kangcheng, KC-5A08), anti-α-Tubulin (Proteintech, 11224-1-AP), anti-JUN (Proteintech, 24909-1-AP), anti-CEBPB (Proteintech, 23431-1-AP), anti-HDAC3 (Proteintech, 10255-1-AP), anti-HIF-1α(Proteintech, 20960-1-AP), and anti-MGMT (Proteintech, 17195-1-AP) antibodies.

Gao Y., Liu B., Feng L., Sun B., He S., Yang Y., Wu G., E G., Liu C., Gao Y., Zhang E, & Zhu B. (2019). Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma. Frontiers in Oncology, 9, 33.

+ Open protocol

+ Expand

Fbw7 Regulation of Stat3 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols

The following antibodies were used in the study: anti-Fbw7 (for IHC) (H00055294-M02, Abnova, Taipei City, Taiwan), anti-Fbw7 (for western blots) (ab109617, Abcam, Cambridge, UK), anti-Stat3, 12640; anti-phospho-Stat3^Tyr705, 4113; anti-Ubiquitin, 3936 (Cell Signaling Technology, Beverly, MA, USA), anti-Myc tag, 16286–1-AP; anti-Flag tag, 66008–2-Ig; and anti-β-actin, 60008–2-Ig; anti-Myc, 10828–1-AP; anti-Notch, 10062–2-AP; anti-Jun, 10024–2-AP; anti-DEK, 16448–1-AP; anti-Mcl1, 16225–1-AP(Proteintech, Rosemont, IL, USA). All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) and Amresco (Dallas, TX, USA).

Yao S., Xu F., Chen Y., Ge Y., Zhang F., Huang H., Li L., Lin D., Luo X., Xu J., Luo D., Zhu X, & Liu Y. (2017). Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation. Journal of Experimental & Clinical Cancer Research : CR, 36, 10.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!